Src Inhibition Is Still a Relevant Target in Pancreatic Cancer
George T, Trevino J, Liu C. Src Inhibition Is Still a Relevant Target in Pancreatic Cancer. The Oncologist 2014, 19: 211-211. PMID: 24457377, PMCID: PMC3926798, DOI: 10.1634/theoncologist.2013-0410.Peer-Reviewed Original Research